<DOC>
	<DOC>NCT01616693</DOC>
	<brief_summary>The percentage of participants with a serologic immune response (seroconversion or four-fold rise in rotavirus IgA antibodies) to rotavirus vaccine at 14 weeks of age among infants receiving zinc or probiotic supplements will be at least 15% higher and significantly better to that of infants who receive a placebo for zinc or probiotic supplement.</brief_summary>
	<brief_title>Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus Vaccines</brief_title>
	<detailed_description />
	<mesh_term>Poliomyelitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<criteria>Infants 3541 days old Live in area under surveillance Current weight â‰¥3.2 kg No syndromic evidence of immunocompromise as determined by medical doctor No prior illness requiring hospitalization No current medical condition as determined by medical doctor which precludes study involvement Available for follow up for duration of study (through approximately 14 weeks of age) Parents/guardians of infant are able to understand and follow study procedures and agree to participate in the study by providing signed informed consent Child has history of atopic symptoms Child has a known digestive system defect Child has history of chronic diarrhea Child has major congenital anomalies Child has received a prior dose of rotavirus vaccine Child has received a prior dose of polio vaccine (beyond the birth dose)</criteria>
	<gender>All</gender>
	<minimum_age>5 Weeks</minimum_age>
	<maximum_age>16 Weeks</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>rotavirus</keyword>
	<keyword>polio</keyword>
	<keyword>zinc supplement</keyword>
	<keyword>probiotic supplement</keyword>
	<keyword>rotavirus vaccine shedding</keyword>
</DOC>